儿科急性淋巴细胞白血病,版本2.2025,NCCN瘤学临床实践指南
Hiroto Inaba1, David Teachey2, Colleen Annesley3
1St. Jude Children's Research Hospital/The University of Tennessee Health Science Center.
Journal of the National Comprehensive Cancer Network : JNCCN
|February 12, 2025
概括
根据目前的证据,NCCN指南为治疗儿科急性淋巴细胞白血病 (ALL) 提供专家建议,重点关注T细胞ALL的诊断和管理.
科学领域:
- 在瘤学瘤学.
- 儿科血液学/瘤学
背景情况:
- 国家综合癌症网络 (NCCN) 制定了基于证据的癌症治疗指南.
- 儿科急性淋巴细胞白血病 (ALL) 需要专门的治疗方案.
- 多学科专家的共识对于准则的制定至关重要.
研究的目的:
- 为儿童T细胞ALL的诊断和管理提供最新的建议.
- 概述儿童ALL的风险分层和风险适应治疗方法.
- 详细介绍各种小儿ALL亚型的治疗策略,包括BCR::ABL1阳性和阴性B细胞系,T细胞系和婴儿ALL.
主要方法:
- 通过多学科专家小组会议制定指导方针.
- 对当前证据的审查,以告知治疗建议.
- 专注于风险评估和分层对量身定制的治疗.
主要成果:
- 涵盖儿童ALL诊断,风险分层和治疗的全面指南.
- 针对BCR的具体建议:ABL1阴性和阳性B细胞系,T细胞系和婴儿ALL.
- 强调支持性护理方面的考虑.
结论:
- "NCCN指南"为儿童ALL的标准化,基于证据的护理提供了一个框架.
- 本选择突出了儿科T细胞ALL诊断和管理的关键方面.
- 遵守指南旨在优化ALL儿童的治疗结果.
更多相关视频
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
29.1K
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
1.3K
相关概念视频
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
967
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
408
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408